Results

Our proven
track record.

  • We represented a University in its spinout of a biopharmaceutical company and subsequent $32 million Series A financing, including an agreement granting exclusive rights to acquire the company and its technology.
  • We represented a specialty pharmaceutical client in its collaboration with a Chinese pharmaceutical company to develop and manufacture pharmaceutical products in China.
  • Our lawyers represented a Singapore-based public company in its joint venture with a privately held U.S. company to develop and market hardware and software products for postal, courier, and logistics markets.
  • We have negotiated joint development agreements with US, Swiss, Canadian, and Chinese pharmaceutical companies relating to both new compounds and generic versions of listed drugs on behalf of biotech and specialty pharmaceutical companies.
  • We represented a U.S. manufacturer in a joint venture with a Chinese partner for the construction of a manufacturing facility in Shanghai.
  • We represented a leading Canadian provider of diagnostic imaging technology in negotiating a series of arrangements to distribute its technology in conjunction with the products of the world’s top medical imaging equipment manufacturers.
  • We represented a U.S.-based pharmaceutical company and its India-based subsidiary in numerous licensing and joint venture transactions with major educational and government organizations in India and represented them in its sale to a British entity. Currently, we represent a principal of the acquired entities in a spinout of these entities, which involves among other issues, special purpose financing arranged through an Indian private equity fund and coordinating U.S. and Indian tax and securities laws.
  • Represented a venture capital fund in its collaboration with a publicly traded Dutch company and a U.S. executive in developing a web-based gaming site in the United Kingdom.

BUSINESS ATTORNEYS

Meet the Licensing, Joint Ventures & Collaborations Team.

RESOURCES

Happenings, headlines and insights.
See what’s new at Davis Malm.

View Our Business Resources

Firm Announcements

February 23, 2026

Andrew D. Myers Named a “Go To Business Transactions Lawyer” by Massachusetts Lawyers Weekly

Read More

Firm Announcements

January 23, 2026

Jamey A. Wachta Finalizes International Licensing Agreement to Expand Access to Sanitation in India

Read More

Publications

November 12, 2025

Navigating the Property Tax Appeal Process: What Property Owners Need to Know

Read More

Publications

August 12, 2025

Exhausting Administrative Remedies in a Tax Appeal, Phil Olsen Published by Massachusetts Lawyers Weekly

Read More

Speaking Engagements

June 25, 2025

Jamey Wachta Presents on AUTM Webinar Focusing on Consulting Agreements Used by Life Sciences Faculty

Read More

Speaking Engagements

June 23, 2025

Philip S. Olsen Presents on BBA Webinar, “Introduction to Careers in Tax Law & Tax Section Social”

Read More

Publications

June 20, 2025

Phil Olsen Serves as Contributing Author for 2023-2024 ABA Sales & Use Tax Deskbook

Read More

Firm Announcements

June 12, 2025

Courtney A. Simmons Named a “Rising Star” by New England Real Estate Journal

Read More

Firm Announcements

June 5, 2025

Davis Malm Attorneys and Practice Areas Recognized by 2025 Chambers USA

Read More

Contact Us

Need Business Counsel?

Get in touch
Scroll to Top